欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/3216/001
药品名称
Abirateron Teva
活性成分
abiraterone acetate 500.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva B.V. Swensweg 5 2031GA Haarlem, Netherlands
参考成员国 - 产品名称
Denmark (DK)
Abirateron "Teva"
互认成员国 - 产品名称
Latvia (LV)
Ireland (IE)
Lithuania (LT)
Austria (AT)
Estonia (EE)
France (FR)
Hungary (HU)
Abirateron Teva 500 mg filmtabletta
Spain (ES)
Bulgaria (BG)
Abiraterone Teva
Portugal (PT)
Czechia (CZ)
Abirateron Teva
Romania (RO)
Greece (GR)
Slovenia (SI)
Sweden (SE)
Croatia (HR)
Germany (DE)
Abirateronacetat-ratiopharm 500 mg Filmtabletten
Norway (NO)
Finland (FI)
Netherlands (NL)
Poland (PL)
Iceland (IS)
许可日期
2022/05/04
最近更新日期
2024/05/15
药物ATC编码
L02BX03 abiraterone
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Abiraterone_DK_H_3216_OuP_21_07_23
Date of last change:2024/09/06
Final PL
|
Abiraterone_DK_H_3216_PIL_21_07_23
Date of last change:2024/09/06
Final SPC
|
Abiraterone_DK_H_3216_SmPC_21_07_23
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase